SPLASH BEVERAGE GROUP INC (SBEV)
AMEXConsumer StaplesBeverages - Wineries & DistilleriesSnapshot 2026-09-04
$0.31-25.92%
Close 2026-08-28 · 1-day change
AMEXConsumer StaplesBeverages - Wineries & DistilleriesSnapshot 2026-09-04
QuarterlyIQ Insights · SBEV
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Unregistered Sales of Equity Securities. On August 25, 2026, Endovia Health Sciences, Inc. (the “Company”) sold and issued a total of 510,951 shares of common stock pursuant to that certain Securities Purchase Agreement dated September 19, 2025 with C/M Capital Master Fund, LP as purchaser (the “ELOC Agreement”) for total gross proceeds of $107,610.62. The ELOC Agreement was previously disclosed in the Company’s Current Report on Form 8-K filed on September 25, 2025. To the extent such sales…
Entry into a Material Definitive Agreement On August 20, 2026, Endovia Health Sciences, Inc. (the “Company”) entered into an Employment Agreement (each, an “Agreement”) with each of Brady Cobb for his employment as Interim Chief Executive Officer of the Company and Michael Bondurant for his employment as Interim Chief Operating Officer of the Company. Pursuant to the Agreements, the Company agreed to compensate Mr. Cobb and Mr. Bondurant as follows for their services: (a) a base salary at the…
Regulation FD Disclosure On August 25, 2026, Endovia Health Sciences, Inc. formerly known as Splash Beverage Group, Inc. (the “Company”) issued a press release announcing that it achieved the first FDA Regulatory Milestone for its CannEpil® veterinary development program under its previously announced collaboration agreement with Lupvindal Biosciences Ltd., formally initiating the regulatory process for the development of CannEpil® as an investigational veterinary pharmaceutical. A copy of th…
Results of Operations and Financial Condition. On August 20, 2026, Splash Beverage Group, Inc. (the “Company”) issued a press release announcing its financial results for the second quarter ended June 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18…
Regulation FD Disclosure On August 5, 2026, the Company issued a press release announcing its entry into the Collaboration Agreement with Lupvindol Biosciences Ltd. for the development and advancement of CannEpil® for veterinary uses. A copy of the press release is furnished as Exhibit 99.1 of this Current Report on Form 8-K. The information in this Item 7.01 (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange A…
Entry into a Material Definitive Agreement On July 31, 2026, Splash Beverage Group, Inc. (the “Company”) entered into a Development and Collaboration Agreement (the “Collaboration Agreement”) with Lupvindol Biosciences Ltd. (“Lupvindol”), pursuant to which Lupvindol has agreed to lead the development of, and all U.S. Food and Drug Administration (“FDA”) regulatory activities for, a new animal drug to be developed from the Company’s pharmaceutical product marketed under the brand name CannEpil…
Entry into a Material Definitive Agreement On July 28, 2026, Splash Beverage Group, Inc. (the “Company”) and Argent BioPharma Limited (ASX/LSE: RGT) (the “Licensor”) entered into an addendum (the “Addendum”) to that certain exclusive global license agreement for CannEpil®, dated July 6, 2026 (the “License Agreement”). Pursuant to the Addendum, the License Agreement was amended to: (i) expand the field of use under the License Agreement to include veterinary applications; (ii) provide for an a…
Entry into a Material Definitive Agreement On July 28, 2026, Splash Beverage Group, Inc. (the “Company”) and Argent BioPharma Limited (ASX/LSE: RGT) (the “Licensor”) entered into an addendum (the “Addendum”) to that certain exclusive global license agreement for CannEpil®, dated July 6, 2026 (the “License Agreement”). Pursuant to the Addendum, the License Agreement was amended to: (i) expand the field of use under the License Agreement to include veterinary applications; (ii) provide for an a…
Entry into a Material Definitive Agreement. On July 15, 2026, Splash Beverage Group, Inc. (the “Company”) entered into amendments to certain settlement agreements, which the Company had previously entered into with three separate prior investors of the Company (the “Investors”) in February 2026. Pursuant to the amendments, the Company and each Investor agreed to extend the due date for the remaining settlement payments payable by the Company to provide that 50% of the remaining unpaid settlem…
Entry into a Material Definitive Agreement. On July 10, 2026, Splash Beverage Group, Inc. (the “Company”) entered into a letter agreement with Decathlon Alpha IV, L.P., the lender under that certain Revenue Loan and Security Agreement dated December 24, 2020, as amended (the “Loan Agreement”), pursuant to which the parties agreed that the Company may satisfy its outstanding obligations under the Loan Agreement totaling $2,834,689 by paying to the lender $301,800.55 on or before August 31, 202…
Unregistered Sales of Equity Securities. From June 30, 2026 through July 8, 2026, the Company sold and issued a total of 9,232,047 shares of common stock pursuant to that certain Securities Purchase Agreement dated September 19, 2025 with C/M Capital Master Fund, LP as purchaser (the “ELOC Agreement”) for total gross proceeds of $1,265,063. The ELOC Agreement was previously disclosed in the Company’s Current Report on Form 8-K filed on September 25, 2025. To the extent such sales are deemed t…
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On July 8, 2026, the Company received notice from NYSE Regulation (the “NYSE”) that the NYSE has determined to accept the Company’s plan to regain compliance with the NYSE American’s shareholders’ equity requirement as outlined in Section 1003(a)(i), (ii), and (iii) of the Company Guide (the “Compliance Plan”), which the Company submitted to the NYSE on May 29, 2026. Pursuant to the Compliance…
Unregistered Sales of Equity Securities. The description of the issuance of the Series D and the terms thereof contained in Items 1.01 and 5.03 of this Current Report on Form 8-K are incorporated herein by reference. Such issuance was exempt from registration under the Securities Act of 1933 pursuant to Section 4(a)(2) thereof and Rue 506(b) thereunder on the basis that the Holder is an accredited investor and the issuance was made in a transaction not involving a public offering.
Entry into a Material Definitive Agreement. On July 6, 2026, Splash Beverage Group, Inc. (the “Company”) entered into an Exclusive License Agreement (the “License Agreement”) with Argent Biopharma Limited (the “Licensor”) pursuant to which the Company acquired the exclusive worldwide rights to the pharmaceutical product marketed under the brand name CannEpil®, comprising the Licensor’s proprietary compounded isolated cannabinoid formulation of CBD and THC isolates in a liquid solution, manufa…
Unregistered Sales of Equity Securities. On June 24, 2026, the Company sold and issued a total of 767,953 shares of common stock pursuant to that certain Securities Purchase Agreement dated September 19, 2025 with C/M Capital Master Fund, LP as purchaser (the “ELOC Agreement”) for total gross proceeds of $117,036. The ELOC Agreement was previously disclosed in the Company’s Current Report on Form 8-K filed on September 25, 2025. To the extent such sales are deemed to be unregistered, the sale…
Chief Operating Officer — Michael Bondurant: The company appointed Michael Bondurant as the Chief Operating Officer, bringing in an experienced executive to lead operations.
Entry into a Material Definitive Agreement. On June 9, 2026, Splash Beverage Group, Inc. (the “Company”) invested $217,479.24 and purchased 2,000,000 common shares and 1,000,000 warrants of Avicanna Inc. (TSX:AVCN) in a private placement transaction. Avicanna is a commercial-stage cannabinoid-based biopharmaceutical company focused on clinical research, patient care, and developing pharmaceutical products. The investment represents a strategic capital allocation aligned with the Company’s pre…
Unregistered Sales of Equity Securities. From May 29, 2026 through June 1, 2026, the Company sold and issued a total of 3,846,332 shares of common stock pursuant to that certain Securities Purchase Agreement dated September 19, 2025 with C/M Capital Master Fund, LP as purchaser (the “ELOC Agreement”) for total gross proceeds of $607,720. The ELOC Agreement was previously disclosed in the Company’s Current Report on Form 8-K filed on September 25, 2025. To the extent such sales are deemed to b…
President — William Meissner: William Meissner resigned as President and all other offices of the Company.
Termination of Material Definitive Agreement. To the extent required by
Entry into a Material Definitive Agreement. On April 28, 2025, Splash Beverage Group, Inc. (the “Company”) borrowed $30,000 from DMF Ventures, LLC (“DMF”). In addition to the loan that has been repaid, the Company granted DMF an option to purchase $300,000 of the Company’s common stock at a per share price equal to 50% of the seven-day VWAP of the Company’s common stock, which option expires on April 27, 2035 . On May 27, 2025, the Company sold Series A-1 Convertible Preferred Stock (the “Ser…
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 29, 2026, the Company received notice from NYSE Regulation (the “NYSE”) that the Company is not in compliance with the shareholders’ equity requirement of $6 million as of December 31, 2025 as outlined in Section 1003(a)(i), (ii), and (iii) of the Company Guide. The NYSE noted that that the Company’s actual shareholders’ equity was ($15,300,828). The Company must submit a plan by May…
The Company believes that such transactions were exempt from registration under Section 4(a)(2) of the Securities Act of 1933 and Rule 506(b) promulgated thereunder.
Director — Francis Knuettel II: Francis Knuettel II was appointed as a new director and joined multiple board committees.
Entry into a Material Definitive Agreement. On April 20, 2026, Splash Beverage Group, Inc. (the “Company”) entered into amendments to certain settlement agreements which the Company had previously entered into with three separate prior investors of the Company (the “Investors”) in February 2026. Pursuant to the amendments, the Company and each Investor agreed to extend the due date for the remaining settlement payments payable by the Company totaling $535,595 (after deducting prior payments t…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.